Search
Close this search box.
Search

Philips, Masimo end legal disputes, sign business partnership

Health technology vendors Philips and Masimo have signed a multi-year business partnership agreement in patient monitoring and select therapy solutions. The partnership combines Masimo’s expertise in non-invasive sensor and signal processing technologies with Philips’ expertise in integrated patient monitoring and therapy solutions.

Both companies have agreed to technology integration and will combine marketing and sales efforts in North America and certain markets in Asia and Europe. As a result of the agreement all pending lawsuits between the two companies are ended. In addition to the marketing and integration commitments, the partnership includes a cash payment of USD 300 million (275 million euro’s) by Philips to Masimo.

Combining solutions

Philips develops patient monitoring solutions with a product portfolio such as multi-parameter bedside monitors to wearable patient monitors, combined with mobile applications and clinical decision support tools. In 2015, some 275 million patients were monitored using Philips’ patient monitoring solutions.  ‘Sensor and signal processing technologies are an essential component of patient monitoring solutions’, Philips states.  ‘Masimo is a prolific innovator in this field’.

In conjunction with the appropriate Philips patient monitoring platform, Masimo’s rainbow SET technology analyzes multiple wavelengths of light to accurately measure total hemoglobin, oxygen content, carboxyhemoglobin, methemoglobin and Pleth Variability Index  non-invasively and continuously. Continuous monitoring of SpHb on a Philips monitor at the point of care provides clinicians with real-time visibility to changes in hemoglobin in between invasive blood samplings.

Pending lawsuits ended

As part of the business partnership agreement, Philips and Masimo have agreed to end all pending lawsuits between the two companies, which includes that Philips is released from paying the USD 467 million (approximately EUR 428 million) jury verdict that was awarded to Masimo in October, 2014.

Philips has agreed to make a USD 300 million cash payment (approximately EUR 275 million) to Masimo in the fourth quarter of 2016; and to invest in the relationship by making certain marketing and product integration commitments over the coming years.

“I am very satisfied that we have reached an agreement that is beneficial for both companies and that we have ended our legal disputes,” said Frans van Houten, CEO of Royal Philips Going forward, Philips and Masimo will completely focus on jointly delivering meaningful innovations to our customers.”

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Mayo Clinic started with its innovations for its ten million patients and demonstrated that its model worked, and that data could be ethically and responsibly used to drive innovations.
John Halamka: 'Create the Fear of Missing Out'
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
AmyWebb-Stephen-Olker
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
Follow us